Zanchetti A - Search Results

1

Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H; HOT Study Group. Zanchetti A, et al. J Hypertens. 2003 Apr;21(4):797-804. doi: 10.1097/00004872-200304000-00024. J Hypertens. 2003. PMID: 12658027

2

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study.

Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A. Ruilope LM, et al. Among authors: zanchetti a. J Am Soc Nephrol. 2001 Feb;12(2):218-225. doi: 10.1681/ASN.V122218. J Am Soc Nephrol. 2001. PMID: 11158211 Clinical Trial.

3

Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.

Zanchetti A, Hansson L, Leonetti G, Rahn KH, Ruilope L, Warnold I, Wedel H. Zanchetti A, et al. J Hypertens. 2002 May;20(5):1015-22. doi: 10.1097/00004872-200205000-00038. J Hypertens. 2002. PMID: 12011664 Clinical Trial.

4

Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk.

Zanchetti A, Hansson L, Dahlöf B, Julius S, Ménard J, Warnold I, Wedel H; HOT Study Group. Zanchetti A, et al. J Hypertens. 2002 Nov;20(11):2301-7. doi: 10.1097/00004872-200211000-00031. J Hypertens. 2002. PMID: 12409970 Clinical Trial.

5

Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE) - a review.

Zanchetti A, Elmfeldt D. Zanchetti A, et al. Blood Press. 2006;15(2):71-9. doi: 10.1080/08037050600771583. Blood Press. 2006. PMID: 16754269 Free article. Review.

6

Hypertension: which aspects of hypertension should we impact on and how?

Zanchetti A, Waeber B. Zanchetti A, et al. J Hypertens Suppl. 2006 Aug;24(5):S2-5. doi: 10.1097/01.hjh.0000240039.97472.f1. J Hypertens Suppl. 2006. PMID: 16936532 Review.

7

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.

Zanchetti A, Mancia G, Black HR, Oparil S, Waeber B, Schmieder RE, Bakris GL, Messerli FH, Kjeldsen SE, Ruilope LM. Zanchetti A, et al. J Hypertens. 2009 Apr;27(4):673-9. doi: 10.1097/HJH.0b013e3283298ea2. J Hypertens. 2009. PMID: 19516168 Review.

8

Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study.

Zanchetti A, Hansson L, Ménard J, Leonetti G, Rahn KH, Warnold I, Wedel H. Zanchetti A, et al. J Hypertens. 2001 Apr;19(4):819-25. doi: 10.1097/00004872-200104000-00020. J Hypertens. 2001. PMID: 11330886 Clinical Trial.

9

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, Larochelle P, McInnes GT, Mallion JM, Ruilope L, Wedel H. Zanchetti A, et al. J Hypertens. 2001 Jun;19(6):1149-59. doi: 10.1097/00004872-200106000-00021. J Hypertens. 2001. PMID: 11403365 Clinical Trial.

10

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group. Lithell H, et al. Among authors: zanchetti a. J Hypertens. 2003 May;21(5):875-86. doi: 10.1097/00004872-200305000-00011. J Hypertens. 2003. PMID: 12714861 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

981 results

Search Page

Filters